SEC Filing Summary: Amedica Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on February 12, 2015. The registrant is incorporated in Delaware and maintains its principal executive offices in Salt Lake City, Utah. The filing reports a specific corporate event rather than a standard financial reporting period.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a regulatory submission event and does not contain financial statements or performance data.
Material Changes and Events
- Item 8.01 Other Events: On February 12, 2015, the company announced the submission of a 510(k) Application to the U.S. Food and Drug Administration (FDA).
- Product Focus: The application concerns "Composite Spinal Interbody Spacers with Porous Silicon Nitride Center."
- Documentation: A press release detailing this submission is attached as Exhibit 99.1 and incorporated by reference.
Guidance, Outlook, and Risks
The filing does not contain management commentary on financial guidance, future outlook, or specific risk factors beyond the inherent regulatory process of an FDA 510(k) submission. No unusual items or contingencies were disclosed in this specific report.
Key Facts for Investor Verification
- Verify the status of the 510(k) Application for Composite Spinal Interbody Spacers with the FDA.
- Review the attached press release (Exhibit 99.1) for detailed product specifications and market implications.
- Confirm the company's current financial position through its most recent 10-K or 10-Q filings, as this 8-K contains no financial data.